2023/2771(DEA)
Adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use
Basic information
2023/2771(DEA)
DEA - Delegated acts procedure
Supplementing 2013/0222(COD)
Subject
4.20.04 Pharmaceutical products and industry
8.40.08 Agencies and bodies of the EU
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 29/06/2023 | Non-legislative basic document published | C(2023)04261 | |
| 29/06/2023 | Initial period for examining delegated act 2.0 month(s) | ||
| 12/07/2023 | Committee referral announced in Parliament | ||
| 06/09/2023 | Delegated act not objected by Parliament |
Technical information
| Procedure reference | 2023/2771(DEA) |
|---|---|
| Procedure type | DEA - Delegated acts procedure |
| Procedure subtype | Examination of delegated act |
| Supplementing 2013/0222(COD) | |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
ENVI/9/12404
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2023)04261 29/06/2023
Transparency
Meetings with interest representatives published in line with the Rules of Procedure
-
Name Date Interest representatives FITZGERALD Frances 22/06/2023 Roche Products Ireland FITZGERALD Frances 03/05/2023 Baxter Healthcare SA